The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.66
Bid: 15.68
Ask: 15.74
Change: -0.04 (-0.25%)
Spread: 0.06 (0.383%)
Open: 15.44
High: 16.20
Low: 15.30
Prev. Close: 15.70
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission of New Ordinary Shares

21 Nov 2016 08:00

RNS Number : 6616P
EnQuest PLC
21 November 2016
 

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN AND THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

EnQuest PLC, 21 November 2016

Placing and Open Offer

Admission of New Ordinary Shares

Further to the announcement made by EnQuest PLC ("EnQuest" or the "Company") on 17 November 2016, the Company announces that 356,738,114 New Ordinary Shares being issued pursuant to the Placing and Open Offer were admitted to listing on the premium listing segment of the Official List and were admitted to trading on the London Stock Exchange's main market for listed securities, in each case with effect from 8.00 a.m. today, 21 November 2016.

It is expected that admission of the New Ordinary Shares to trading on NASDAQ Stockholm will become effective later today.

The enlarged share capital of the Company following Admission will be 1,159,398,871 Ordinary Shares in aggregate. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company.

This announcement should be read in conjunction with the full text of the combined circular and prospectus (the "Prospectus") published by the Company on 14 October 2016 in connection with the Placing and Open Offer. Unless defined herein, capitalised terms used in this announcement shall have the meaning attributed to them in the Prospectus.

ENQUIRIES

EnQuest PLC

Amjad Bseisu (Chief Executive)

Jonathan Swinney (Chief Financial Officer)

Michael Waring (Head of Communications & Investor Relations)

Tel: +44 (0)20 7925 4900

 

Sponsor and Joint Bookrunner

J.P. Morgan Cazenove

Barry Weir

Jamie Riddell

Charles Pretzlik

 

Tel: +44 (0)20 7742 4000

 

Joint Bookrunner

Bank of America Merrill Lynch

Julian Mylchreest

Richard Abel

Daniel Norman

 

Tel: +44 (0)20 7628 1000

IMPORTANT NOTICE

This announcement has been issued by and is the sole responsibility of EnQuest. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may or should be placed by any person for any purpose whatsoever on the information contained in this announcement or on its accuracy or completeness. The information in this announcement is subject to change.

This announcement does not contain or constitute an offer to sell or the solicitation of an offer to purchase securities to any person with a registered address in, or who is resident in, any Excluded Territory or in any jurisdiction in which such an offer or solicitation is unlawful. None of the securities referred to herein have been or will be registered under the relevant laws of any state, province or territory in any Excluded Territory. Subject to certain limited exceptions, none of these materials will be released, published, distributed or forwarded in or into any Excluded Territory.

 

This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, any securities in any jurisdiction. No offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, any securities will be made in any jurisdiction in which such an offer or solicitation is unlawful. The information contained in this announcement is not for release, publication or distribution to persons in the United States or any other Excluded Territory, and should not be distributed, forwarded to or transmitted in or into any jurisdiction, where to do so might constitute a violation of local securities laws or regulations.

 

This announcement has been prepared in accordance with English law, the EU Market Abuse Regulation and the Disclosure Guidance Rules and Transparency Rules of the Financial Conduct Authority and information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside England.

 

The distribution of this announcement into jurisdictions other than the United Kingdom and Sweden may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction. In particular, subject to certain exceptions, this announcement should not be distributed, forwarded to or transmitted in or into the United States or any other Excluded Territory.

 

 

NOTICE TO ALL INVESTORS

 

J.P. Morgan Securities plc (which conducts its UK investment banking services as "J.P. Morgan Cazenove") and Merrill Lynch International ("BofA Merrill Lynch") are each authorised by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority. J.P. Morgan Cazenove and BofA Merrill Lynch are acting for EnQuest and are acting for no one else in connection with the Placing and Open Offer and will not regard any other person as a client in relation to the Placing and Open Offer and will not be responsible to anyone other than EnQuest for providing the protections afforded to their respective clients, nor for providing advice in connection with the Placing and Open Offer or any other matter, transaction or arrangement referred to herein.

 

 

No person has been authorised to give any information or to make any representations other than those contained in this announcement and the Prospectus and, if given or made, such information or representations must not be relied on as having been authorised by EnQuest or J.P. Morgan Cazenove or BofA Merrill Lynch. Subject to the Listing Rules, the Prospectus Rules and the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the issue of this announcement shall not, in any circumstances, create any implication that there has been no change in the affairs of EnQuest since the date of this announcement or that the information in it is correct as at any subsequent date.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISFEASWFFMSESF
Date   Source Headline
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 202410:25 amRNSDirector/PDMR Shareholding
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20243:00 pmRNSAnnual Financial Report
28th Mar 20247:01 amRNSResults for the year ended 31 December 2023
28th Mar 20247:00 amRNSDirectorate Change
28th Feb 202411:22 amRNSTotal Voting Rights
15th Feb 20247:00 amRNSFebruary Operations Update
30th Jan 202410:00 amRNSTermination of reporting issuer status in Canada
28th Dec 202310:01 amRNSTotal Voting Rights
22nd Dec 20237:00 amRNSSale of 15% of Bressay and EnQuest Producer FPSO
20th Dec 20234:46 pmRNSHolding(s) in Company
18th Dec 20234:00 pmRNSDirector Change
11th Dec 202311:34 amRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSDirectorate Change - EnQuest New Energy Leadership
5th Dec 20233:30 pmRNSConfirmation of delisting date
5th Dec 20239:30 amRNSSubmission of delisting application
4th Dec 20235:34 pmRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSEnQuest November Operations Update
24th Nov 20239:00 amRNSApplication for Block Listing
30th Oct 20234:50 pmRNSDirector/PDMR Shareholding
30th Oct 20232:00 pmRNSNasdaq Stockholm delisting update
28th Sep 20233:00 pmRNSHolding(s) in Company
26th Sep 202310:03 amRNSPDMR Notification
13th Sep 202311:04 amRNSDirectorate Change
5th Sep 20237:02 amRNSNasdaq Stockholm delisting application
5th Sep 20237:01 amRNSBoard appointment
5th Sep 20237:00 amRNSHalf-year Results
25th Aug 20232:09 pmRNSTerm loan facility agreement
19th Jul 20232:20 pmRNSDirector/PDMR Shareholding
22nd Jun 202312:06 pmRNSReport on Payments to Govts
6th Jun 20239:02 amRNSResult of AGM
5th Jun 20233:00 pmRNSHolding(s) in Company
24th May 20237:00 amRNSEnQuest May Operations Update
18th May 20232:30 pmRNSEnQuest awarded offer of carbon storage licences
9th May 20237:00 amRNSEnQuest Malaysia Update
28th Apr 20232:00 pmRNSNotice of AGM
25th Apr 20239:00 amRNSAnnual Financial Report
13th Apr 20234:54 pmRNSDirectorate Change
5th Apr 20237:00 amRNSResults for the year ended 31 December 2022
17th Mar 20237:00 amRNS2022 Preliminary Results - revised date
15th Mar 202311:00 amRNSHolding(s) in Company
17th Feb 20237:00 amRNSTrading Statement
20th Dec 20221:35 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSChairman succession
24th Nov 20227:00 amRNSOperations Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.